Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002088344-25-000003·Verve Capital Ltd
Schedule 13G ownership disclosure
Vor BioPharma Inc
Common Stock, $0.0001 par value per share · CUSIP: 929033207
Event date: 2025-09-18
- Filing-level shares
- 760,699.00
- Percent of class
- 9.9%
- Verve Capital Limited
Shares: 760,699.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002088344-25-000003
- Form type
- SCHEDULE 13G
- Filer
- Verve Capital Ltd
- CIK
- CIK 2088344
- Filed
- Sep 26, 2025
- Reporting period
- Sep 18, 2025
- Description
- Schedule 13G beneficial ownership